Scholarly Index
David B. Sacks
National Institutes of Health; 23,135 total citations; 317 total publications; best world rank #47
National Institutes of Health
23,135Total citations
317Total publications
77H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes Management and Research | Lifetime | 146 | US 75 | 99.35 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 82 | US 40 | 98.67 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 136 | US 80 | 98.83 |
| Metabolism, Diabetes, and Cancer | Lifetime | 404 | US 189 | 98.45 |
| Diabetes and associated disorders | Lifetime | 596 | US 231 | 97.78 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 628 | US 264 | 98.01 |
| Melanoma and MAPK Pathways | Lifetime | 248 | US 130 | 97.30 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 241 | US 110 | 95.27 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 583 | US 245 | 94.32 |
| 14-3-3 protein interactions | Lifetime | 236 | US 108 | 91.01 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 47 | US 29 | 88.03 |
| Diabetes Management and Research | 2021-2025 | 656 | US 253 | 92.93 |
| Diabetes and associated disorders | 2021-2025 | 660 | US 229 | 88.81 |
| Melanoma and MAPK Pathways | 2021-2025 | 404 | US 136 | 82.35 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 585 | US 138 | 63.60 |